Literature DB >> 25332523

Hepatosplenic T cell lymphoma: a rare case report.

Monalisa Hui1, Shantveer G Uppin1, Tara Roshni Paul1, N Beerappa2.   

Abstract

Hepatosplenic T cell lymphoma is a rare form of extra nodal and systemic neoplasm derived from cytotoxic T cells and represents less than 1 % of all non Hodgkins lymphoma. Here we present a case of hepatosplenic T cell lymphoma in a 30 year old male who presented with icterus, pancytopenia and hepatosplenomegaly, highlighting the diagnostic conundrum and pointers towards an accurate diagnosis. Histologically the sinusoids of liver and splenic red pulp were infiltration by CD 3 positive neoplastic lymphoid cells. The pattern of marrow involvement was very subtle and diagnosis was difficult to establish without the help of immunohistochemistry. This case highlights the importance of considering hepatosplenic T cell lymphoma as differential diagnosis in the clinical setting of pancytopenia with hepatosplenomegaly to allow timely diagnosis of these aggressive neoplasms.

Entities:  

Keywords:  Hepatosplenomegaly; Lymphoma; Pancytopenia; T cell

Year:  2012        PMID: 25332523      PMCID: PMC4192252          DOI: 10.1007/s12288-012-0219-y

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  11 in total

1.  Hepatosplenic gamma/delta T-cell lymphoma in bone marrow. A sinusoidal neoplasm with blastic cytologic features.

Authors:  F Vega; L J Medeiros; C Bueso-Ramos; D Jones; R Lai; R Luthra; L V Abruzzo
Journal:  Am J Clin Pathol       Date:  2001-09       Impact factor: 2.493

2.  Hepatosplenic T-cell lymphoma: clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases.

Authors:  Chang-li Lu; Yuan Tang; Qun-pei Yang; Mi Wang; Sha Zhao; Cheng-feng Bi; Neng-gang Jiang; Wen-yan Zhang; Jian-ping Liu; Xia Xu; Wei-ping Liu
Journal:  Hum Pathol       Date:  2011-06-17       Impact factor: 3.466

Review 3.  Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990.

Authors:  E Weidmann
Journal:  Leukemia       Date:  2000-06       Impact factor: 11.528

4.  Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.

Authors:  C B Cooke; L Krenacs; M Stetler-Stevenson; T C Greiner; M Raffeld; D W Kingma; L Abruzzo; C Frantz; M Kaviani; E S Jaffe
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

5.  Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta.

Authors:  J P Farcet; P Gaulard; J P Marolleau; J P Le Couedic; T Henni; M F Gourdin; M Divine; C Haioun; S Zafrani; M Goossens
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

6.  Hepatosplenic gamma-delta T-cell lymphoma: clinicopathological features and treatment.

Authors:  G S Falchook; F Vega; N H Dang; F Samaniego; M A Rodriguez; R E Champlin; C Hosing; S Verstovsek; B Pro
Journal:  Ann Oncol       Date:  2009-02-23       Impact factor: 32.976

7.  Hepatosplenic T cell lymphoma with no expression of cytotoxic molecules.

Authors:  Y Sadahira; K Notohara; T Manabe
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

8.  Expression of cytotoxic molecule TIA-1 in malignant lymphomas mimicking fulminant hepatitis.

Authors:  Y Sadahira; K Ohmoto; S Yamamoto; H Nishihara; H Wada; Y Yawata; T Manabe
Journal:  Pathol Int       Date:  1998-09       Impact factor: 2.534

Review 9.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

Review 10.  Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients.

Authors:  Karim Belhadj; Felix Reyes; Jean-Pierre Farcet; Herve Tilly; Christian Bastard; Regis Angonin; Eric Deconinck; Frederic Charlotte; Veronique Leblond; Eric Labouyrie; Pierre Lederlin; Jean-Francois Emile; Beatrice Delmas-Marsalet; Bertrand Arnulf; Elie-Serge Zafrani; Philippe Gaulard
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.